<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=stada+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss"><channel><title>stada pharma - BingNews</title><link>http://www.bing.com/news/search?q=stada+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>stada pharma</title><link>http://www.bing.com/news/search?q=stada+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Stada reports rosy earnings as CEO tempers expectations around possible sale, IPO</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a32f8baf28442febacff7f6e4707600&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fgermanys-stada-reports-rosy-earnings-first-half-2024-ceo-tempers-sales-rumors&amp;c=7250103409156814667&amp;mkt=en-us</link><description>As Stada Arzneimittel’s private equity owners continue to weigh their options around a potential sale or public offering, the German drugmaker gave a good indication Wednesday of exactly what it can ...</description><pubDate>Wed, 28 Aug 2024 09:25:00 GMT</pubDate><News:Source>FiercePharma</News:Source></item><item><title>STADA: sale of two Russian production facilities successfully closed – personnel reduction goal in the context of &quot;STADA – build the future&quot; reached earlier than planned</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a32f8baf28442febacff7f6e4707600&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fstada-sale-of-two-russian-production-facilities-successfully-closed-%25e2%2580%2593-personnel-reduction&amp;c=4935860615541080355&amp;mkt=en-us</link><description>STADA: sale of two Russian production facilities successfully closed – personnel reduction goal in the context of &quot;STADA – build the future&quot; reached earlier than planned Bad Vilbel, September 25, 2012 ...</description><pubDate>Tue, 25 Sep 2012 03:27:00 GMT</pubDate><News:Source>FiercePharma</News:Source></item><item><title>Stada Group to buy Biopharma’s prescription, consumer health</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a32f8baf28442febacff7f6e4707600&amp;url=https%3a%2f%2fwww.pehub.com%2fstada-group-to-buy-biopharmas-prescription-consumer-health%2f&amp;c=11032456851513757429&amp;mkt=en-us</link><description>Stada Group said Dec. 2 that it is buying the pharmaceutical prescription and consumer health business of Biopharma. Financial terms weren’t announced. The deal includes Biopharma’s production ...</description><pubDate>Sun, 01 Dec 2019 16:00:00 GMT</pubDate><News:Source>PE Hub</News:Source></item><item><title>STADA ranks among top 10% of pharma firms on sustainability</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a32f8baf28442febacff7f6e4707600&amp;url=https%3a%2f%2ffox59.com%2fbusiness%2fpress-releases%2fein-presswire%2f607271304%2fstada-ranks-among-top-10-of-pharma-firms-on-sustainability%2f&amp;c=13272542608934953115&amp;mkt=en-us</link><description>STADA’s commitment to sustainable development stems from the Group’s purpose of Caring for People’s Health as a Trusted Partner.” — Peter Goldschmidt, STADA ...</description><pubDate>Tue, 20 Dec 2022 03:08:00 GMT</pubDate><News:Source>FOX59 News</News:Source></item><item><title>Crescita Therapeutics and STADA Enter 15-Country Exclusive Licensing Agreement for Pliaglis&#174;</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a32f8baf28442febacff7f6e4707600&amp;url=https%3a%2f%2fwww.nasdaq.com%2fpress-release%2fcrescita-therapeutics-and-stada-enter-15-country-exclusive-licensing-agreement-for&amp;c=14114208265781680201&amp;mkt=en-us</link><description>LAVAL, Qu&#233;bec &amp; BAD VILBEL, Germany--(BUSINESS WIRE)-- Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (“Crescita”), a growth-oriented, innovation-driven ...</description><pubDate>Wed, 18 Aug 2021 04:46:00 GMT</pubDate><News:Source>Nasdaq</News:Source></item><item><title>Exclusive: Germany's Stada asks Berlin to help secure its future in Ukraine</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a32f8baf28442febacff7f6e4707600&amp;url=https%3a%2f%2fwww.reuters.com%2fbusiness%2fhealthcare-pharmaceuticals%2fgermanys-stada-asks-berlin-help-secure-its-future-ukraine-2023-04-04%2f&amp;c=6388895137255217134&amp;mkt=en-us</link><description>FRANKFURT, April 4 (Reuters) - Generic drugmaker Stada has asked the German government to seek assurances from Ukraine that the company can continue operations there even though it also does business ...</description><pubDate>Tue, 04 Apr 2023 10:23:00 GMT</pubDate><News:Source>Reuters</News:Source></item></channel></rss>